Company: Serina Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2024-04-01

Corporate Action: Spin-off

Type: New

Accession Number: 000149315224012530

Comments: The document describes a merger transaction, not a spin-off.

Document Link: View Document